CVRX – cvrx, inc. (US:NASDAQ)

News

Wolf Popper LLP Announces Investigation on Behalf of CVRx, Inc. Investors
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance
CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy
CVRx (NASDAQ:CVRX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com